Volpara Health Technologies Limited

Equities

VHT

NZVHTE0001S6

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. Other stock markets 07:10:11 03/05/2024 BST			5-day change	1st Jan Change
1.145 ^AUD	+0.44%		0.00%	+3.62%

05-21	Volpara Health Technologies Narrows Fiscal 2024 Loss as Revenue Rises 22%	MT
05-21	Lunit Implements Scheme to Acquire Volpara Health Technologies	MT

Volpara Health Technologies Limited Appoints Fred Struve as Joint Company Secretary

October 20, 2022 at 10:20 pm

Volpara Health Technologies Limited announced that Fred Struve has been appointed as Joint Company Secretary, effective immediately, in addition to him continuing his role as General Counsel. Fred has held the position of General Counsel since September 2021.

Latest news about Volpara Health Technologies Limited

Volpara Health Technologies Narrows Fiscal 2024 Loss as Revenue Rises 22%	05-21	MT
Lunit Implements Scheme to Acquire Volpara Health Technologies	05-21	MT
Volpara Health Technologies Limited(ASX:VHT) dropped from S&P/ASX Emerging Companies Index	05-05	CI
Volpara to Delist After Court Approves Acquisition by Lunit	05-03	MT
Volpara Health Technologies Secures Approval for Lunit’s Proposed Takeover	04-12	MT
Transcript : Volpara Health Technologies Limited - Shareholder/Analyst Call	04-12
Volpara Health Technologies Limited Launches MQSA Compliance Software at the Society for Breast Imaging Symposium	04-11	CI
Volpara Health Technologies Ltd. to Showcase AI Software for Breast Centers at NCBC 2024	03-15	CI
Volpara Health Technologies Ltd. to Highlight Growing Ai Suite for Mammography At ECR 2024, Including New Lunit Distribution Agreement	02-21	CI
Lunit to Take Over Volpara Health; Lunit Shares Decline 4%	12-15	MT
Lunit Inc. agreed to acquire Volpara Health Technologies Limited from Harbour Asset Management Limited and others for AUD 300 million.	12-12	CI
Transcript : Volpara Health Technologies Limited, H1 2024 Earnings Call, Nov 21, 2023	11-20
Volpara Health Technologies Limited Reports Earnings Results for the Half Year Ended September 30, 2023	11-20	CI
Transcript : Volpara Health Technologies Limited, Q2 2024 Earnings Call, Oct 17, 2023	16/10/23
Volpara Health Technologies Divests Interest in Software Company RevealDX	28/08/23	MT
An Unknown buyer acquired 4% stake in Reveal DX fromVolpara Health Technologies Limited.	27/08/23	CI
Transcript : Volpara Health Technologies Limited - Shareholder/Analyst Call	17/08/23
Transcript : Volpara Health Technologies Limited, Q1 2024 Earnings Call, Jul 21, 2023	21/07/23
Volpara Health Technologies Secures AU$1.4 Million Contract for Mammography Screening Software	07/06/23	MT
Transcript : Volpara Health Technologies Limited, 2023 Earnings Call, May 25, 2023	25/05/23
Volpara Health Technologies Limited Reports Earnings Results for the Full Year Ended March 31, 2023	24/05/23	CI
Transcript : Volpara Health Technologies Limited, Q4 2023 Earnings Call, Apr 28, 2023	28/04/23
Volpara Health Technologies Expands Contract With US Hospital Systems Operator; Shares Up 6%	11/04/23	MT
Volpara Health Technologies Updates Contract with US Imaging Provider; Shares Fall 5%	06/04/23	MT
Volpara Health Technologies Ltd. to Showcase Comprehensive Product Offerings at NCoBC 2023	23/03/23	CI

Chart Volpara Health Technologies Limited

Duration

Period

Chart Volpara Health Technologies Limited

More charts

Company Profile

Volpara Health Technologies Limited is a New Zealand-based company, which makes software for healthcare providers to understand cancer risk, enabling patients to make personal care decisions and guide recommendations about additional imaging, genetic testing and other interventions. Its artificial intelligence (AI)-powered image analysis enables radiologists to quantify breast tissue with precision and helps technologists produce mammograms with optimal image quality, positioning, compression and dose. Its software streamlines operations and provides performance insights that support continuous quality improvement. Its software is used in over 2,000 facilities by more than 5,600 technologists, impacting nearly 15 million patients globally. It helps providers conduct more than three million cancer risk assessments each year and can be deployed stand-alone or fully integrated with electronic health record systems, mammography reporting systems, imaging hardware and genetic laboratories.

Sector

Advanced Medical Equipment & Technology

Calendar

17/11/2024 - Q2 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Volpara Health Technologies Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sector Medical Software & Technology Services

	1st Jan change	Capi.
VOLPARA HEALTH TECHNOLOGIES LIMITED	+3.62%	193M
VEEVA SYSTEMS INC.	+5.91%	32.95B
PRO MEDICUS LIMITED	+20.73%	8.01B
SECTRA AB	+34.25%	4.38B
EVOLENT HEALTH, INC.	-29.52%	2.67B
OMNICELL, INC.	-13.29%	1.5B
VERADIGM INC.	-28.02%	1.27B
LUNIT INC.	-30.53%	1.2B
SIMULATIONS PLUS, INC.	+11.35%	996M
B-SOFT CO.,LTD.	-38.17%	864M

Medical Software & Technology Services